| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Esperion Therapeutics, Inc. | Director | Stock Option (right to buy) | 88K | $105K | $1.62 | May 29, 2025 | Direct |
| MARINUS PHARMACEUTICALS INC | Director | Common Stock | 6.44K | $57.5K | $8.93 | Feb 4, 2022 | Direct |
| MARINUS PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 12.4K | Feb 4, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics, Inc. | May 29, 2025 | 1 | $0 | 4 | Jun 2, 2025 | Director |
| ESPR | Esperion Therapeutics, Inc. | May 23, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
| ESPR | Esperion Therapeutics, Inc. | Jun 15, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
| ESPR | Esperion Therapeutics, Inc. | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| MRNS | MARINUS PHARMACEUTICALS INC | Feb 4, 2022 | 2 | $0 | 4 | Feb 7, 2022 | Director |
| ESPR | Esperion Therapeutics, Inc. | May 27, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |